ESAC point prevalence methodology to assess antimicrobial consumption and quality of prescribing in an Australian setting

Jennifer A Kieran, Rosaleen G O’Doherty and Bernard J Hudson
Med J Aust 2011; 194 (2): . || doi: 10.5694/j.1326-5377.2011.tb04183.x
Published online: 17 January 2011

To the Editor: Point prevalence studies have been used for many years as markers of antimicrobial consumption,1,2 but they have suffered from a lack of standardisation with regard to the populations studied and the data collected. These deficiencies make it difficult to generalise the data outside the study populations. In recent years, the European Surveillance of Antimicrobial Consumption (ESAC) has sought to overcome these weaknesses by implementing a web-based point prevalence survey in 20 European countries using standardised definitions for site of infection, indication and quality indicators, such as whether the indication for prescription is documented in the case notes.3 As Australian studies of this type have not been published, we undertook a pilot study to assess whether this point prevalence tool is feasible and useful in an Australian setting.

  • Jennifer A Kieran
  • Rosaleen G O’Doherty
  • Bernard J Hudson

  • Royal North Shore Hospital, Sydney, NSW.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.